The content of African diets is adequate to achieve optimal efficacy with fixed-dose artemether-lumefantrine: a review of the evidence.
about
Update on the efficacy, effectiveness and safety of artemether-lumefantrine combination therapy for treatment of uncomplicated malaria.Early clinical development of artemether-lumefantrine dispersible tablet: palatability of three flavours and bioavailability in healthy subjectsArtemether-lumefantrine: an option for malaria.Artemether-Lumefantrine Combination Therapy for Treatment of Uncomplicated Malaria: The Potential for Complex Interactions with Antiretroviral Drugs in HIV-Infected Individuals.Implementation of artemether-lumefantrine treatment policy for malaria at health facilities in Tanzania.Efficacy of artemether-lumefantrine in area of high malaria endemicity in India and its correlation with blood concentration of lumefantrine.Similar efficacy and safety of artemether-lumefantrine (Coartem®) in African infants and children with uncomplicated falciparum malaria across different body weight rangesSurveillance of the efficacy of artemether-lumefantrine and artesunate-amodiaquine for the treatment of uncomplicated Plasmodium falciparum among children under five in Togo, 2005-2009.Safety and efficacy of re-treatments with pyronaridine-artesunate in African patients with malaria: a substudy of the WANECAM randomised trial.Evaluation of two novel tablet formulations of artemether-lumefantrine (Coartem) for bioequivalence in a randomized, open-label, two-period study.Understanding the pharmacokinetics of Coartem.Artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria.Efficacy and safety of artemether-lumefantrine and dihydroartemisinin-piperaquine in the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children aged less than five years: results of an open-label, randomized, single-centre studyArtemether-lumefantrine: an oral antimalarial for uncomplicated malaria in children.Novartis Malaria Initiative: best practice example of pharmaceutical industry's engagement in the fight against malaria.Artemether and lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in sub-Saharan Africa.Oil-Fortified Maize Porridge Increases Absorption of Lumefantrine in Children with Uncomplicated Falciparum Malaria.Comparable lumefantrine oral bioavailability when co-administered with oil-fortified maize porridge or milk in healthy volunteers.Coartem(®): a decade of patient-centric malaria management.Comparative evaluation of efficacy and safety of artesunate-lumefantrine vs. artemether-lumefantrine fixed-dose combination in the treatment of uncomplicated Plasmodium falciparum malaria.Artesunate/mefloquine paediatric formulation vs. artemether/lumefantrine for the treatment of uncomplicated Plasmodium falciparum in Anonkoua kouté, Côte d'Ivoire.Effect of food on the pharmacokinetics of piperaquine and dihydroartemisinin.No robust evidence of lumefantrine resistance.Use of artemether-lumefantrine to treat malaria during pregnancy: what do we know and need to know?Effectiveness of artesunate-amodiaquine vs. artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in Nanoro, Burkina Faso: a non-inferiority randomised trial.Development of medicines for the control and elimination of malaria
P2860
Q33635019-394EE670-31A8-4803-8CE5-E293AE48E2CEQ34154423-87AD8779-A0DF-47D1-AE2C-DDEE946D68F6Q34267667-A05C9E91-3DA3-4559-8B25-AD8A24E3C7D3Q35692270-507E3510-E6A6-47B3-9748-451BE81C8AFFQ35727781-F0DE9273-DD1E-45AB-9E2D-73A600427D53Q35771768-AF355D03-EE72-405E-B97A-59B2077B0B99Q35834482-68BA2D19-5796-4BCB-8392-E07D2F0372F7Q36427202-F18935A2-19D3-4A67-98BF-CD83BFDC2228Q36501878-61B91004-93C4-48FF-B9BC-6FF3FD25D432Q37356688-5B9E3FBC-92EA-4D6E-9039-A147FBBB8C0BQ37383289-51135937-8183-40E0-AE93-344A93650546Q37388596-D2D75EE3-0623-4EC6-8E33-B54E68617BDBQ37562847-9E9C3F3D-F0D5-4B97-99B7-0B22E474E7CAQ37579921-74E1A522-5327-4FB1-972A-D7F39E2FEA5BQ37857327-C5B90009-947F-4FC8-9FC6-48E05ED9241CQ38082548-6F274DAC-DD82-4C2B-8317-CC127330B219Q38852053-12C9E571-0E19-469A-9BA4-80659F30B7F3Q38865815-E42C275E-6388-41E0-B999-2B4C6BB011A9Q39042892-C3147D56-E82E-446E-B9F3-E684080093DCQ40254622-000D292C-B038-477D-B431-92ACFA4009CAQ40338028-0DE1CA7F-EFA6-448F-9683-E8F9DE6FE53EQ41040998-35E77795-80AF-4798-B3D4-FD9DD238B904Q42546115-E131D032-589B-4F15-A19F-B69BEF3F73FDQ42712939-4DA4E02D-A37F-41A6-AB7C-1F457A0614B2Q43927844-B4324104-F1F3-4D77-BE45-B2982CF3BD37Q57019124-CD525D8E-D70A-402E-88D6-6AE7F1A5D059
P2860
The content of African diets is adequate to achieve optimal efficacy with fixed-dose artemether-lumefantrine: a review of the evidence.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
The content of African diets i ...... ine: a review of the evidence.
@en
The content of African diets i ...... ine: a review of the evidence.
@nl
type
label
The content of African diets i ...... ine: a review of the evidence.
@en
The content of African diets i ...... ine: a review of the evidence.
@nl
prefLabel
The content of African diets i ...... ine: a review of the evidence.
@en
The content of African diets i ...... ine: a review of the evidence.
@nl
P2093
P2860
P50
P921
P356
P1433
P1476
The content of African diets i ...... ine: a review of the evidence.
@en
P2093
Alice Ndong
Gilbert Kokwaro
Nathan Mulure
Obiyo Nwaiwu
Zulfiqarali G Premji
P2860
P2888
P356
10.1186/1475-2875-7-244
P5008
P577
2008-11-25T00:00:00Z
P5875
P6179
1044258978